MAP[Microneedle Array Patches] Technology of EaseJect.
Our microneedle platform is based on a bioabsorbable microarray patch technology that enables the stable and efficient delivery of active pharmaceutical ingredients (APIs). Using this platform, we have successfully formulated a wide range of APIs within the microneedle matrix and developed optimized microneedle patches tailored to each ingredient. This technology allows conventional drugs to be reformulated into more convenient and patient-friendly dosage forms, offering a promising alternative to traditional administration routes.
EaseJect’s MAP technology is based on an advanced micro-projection structure designed to gently penetrate the skin barrier and efficiently deliver active ingredients. The product provides an almost painless and easy-to-use experience, making it suitable for various pharmaceutical and cosmetic applications.
The image is a conceptual illustration of EaseJect’s next-generation MAP platform. Actual product specifications may vary depending on application and regulatory requirements.
News & Event
Recognized as a R&D Company
EaseJect has been officially certified as a research and development (R&D) enterprise by the National Research, Development and Innovation Office (NKFIH) of Hungary — a significant milestone in our innovation journey.
july. 2025
Signs Strategic Preclinical Research Agreement with Pharminvivo
EaseJect Kft has entered into a strategic preclinical research agreement with Pharminvivo Ltd., a leading Hungarian preclinical research organization.
October. 2025
Initiation of the GLP Certification Process Toward the Highest Quality Standards
We have fully initiated the official procedures for obtaining GLP certification and are systematically preparing all required documentation and compliance measures.
December. 2025